#United States #Grand Forks, North Dakota #Hormone Therapy #Society of Proactive Medicine #BHRT

Introduction

A revolutionary step has been taken in the field of hormone therapy with the formation of The Society of Proactive Medicine. This new independent nonprofit has been established by a consortium of esteemed healthcare professionals dedicated to improving practices surrounding hormone therapy, including bio-identical hormone replacement therapy. With quality and patient safety at the forefront, this organization aims to address significant gaps in education, establish clear clinical guidelines, and ensure that therapies are administered based on the most current scientific evidence.

Mission and Vision

The Society of Proactive Medicine has a clearly defined goal: to modernize hormone replacement therapy through evidence-based practices, comprehensive education, and transparent communication. By doing so, the Society intends to raise standards within hormone medicine, replacing outdated narratives with cutting-edge, physiology-based science that emphasizes individualized treatment. The objective is to create the first comprehensive clinical practice guidelines for bio-identical hormone replacement therapy (BHRT) that address gaps while equipping the public with trustworthy information regarding its risks, benefits, and alternatives.

The Society is committed to prioritizing high-quality medical research paired with expert clinical practices to improve metabolic health, lower disease risk, and promote patient-centered health. Recognizing the need for an independent authority free from industry influence, co-founders Dr. Nicole Lovat and Dr. Peter Fotinos are leading this initiative to unify practices and correct existing misinformation in the arena of hormone therapy.

Foundations of Evidence-Based Care

As part of their foundational work, The Society of Proactive Medicine plans to begin disseminating clinical practice guidelines, training materials, and research summaries in 2026, designed to bridge existing educational gaps and enhance patient outcomes. The focus will be on:

• - Promoting standards of care that reflect the latest medical research concerning hormone therapy.
• - Educating the public on the safe administration of BHRT.
• - Supporting cross-disciplinary training among clinicians to ensure comprehensive healthcare.
• - Advocating for proactive health measures to maintain hormonal balance and optimization.

Who are the Founders?

The organization is spearheaded by a diverse and expert-led team. Dr. Nicole Lovat, a dual board-certified family physician, brings a wealth of experience in drug science and clinical practice. Dr. Peter Fotinos, a clinical physician specializing in hormone therapy, aims to challenge outdated methodologies while advancing patient-centered care. Together with numerous other respected experts from various medical fields including endocrinology, gynecology, and urology, they aim to establish credible and comprehensive guidelines for hormone care.

Advancements in Hormone Therapy Policy

The formation of this organization coincides with significant advancements in regulatory perspectives on hormone therapy. In a critical change, the U.S. Food and Drug Administration (FDA) has focused on updating old warnings related to women's hormone therapy, thus fostering an urban shift toward evidence-based bio-identical hormone treatment practices. By facilitating this level of transformation, The Society of Proactive Medicine aspires to enhance the public's understanding of hormone therapy while advocating for patient well-being and education.

Conclusion

In a healthcare environment often characterized by reactive care, The Society of Proactive Medicine seeks to redefine hormone therapy standards, placing patient safety, education, and individualized care at the center of their mission. Through transparent practices and a reliance on scientific evidence, this nonprofit aims to shift the paradigm of hormone therapy from one predicated on fear and misinformation to one based on knowledge and empowerment. With a multidisciplinary approach, the Society is poised to lead the charge toward a future where hormone therapy is administered effectively, safely, and optimally for all patients.